Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Aetna Inc    AET

AETNA INC (AET)
Mes dernières consult.
Most popular
Delayed Quote. Delayed  - 07/26 10:01:46 pm
155.69 USD   -0.36%
07/25DJThe Boss Wants You Back in the Office
07/20 AETNA : to Announce Second-Quarter 2017 Results
07/11 AETNA INC : ex-dividend day
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Goldman M&A head Sykes joins management committee

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/19/2012 | 11:07pm CEST

Gene Sykes, global head of Goldman Sachs Group Inc's (>> Goldman Sachs Group, Inc.) mergers and acquisitions business, has been named to the investment bank's management committee, according to an internal memo.

Gene Sykes, global head of Goldman Sachs Group Inc's (>> Goldman Sachs Group, Inc.) mergers and acquisitions business, has been named to the investment bank's management committee, according to an internal memo.

The 54-year-old investment banker joins 28 other executives on the powerful committee, which includes Chief Executive Lloyd Blankfein and Chief Operating Officer Gary Cohn, and influences decisions about Goldman's business strategy and operations.

Sykes' appointment comes just nine days after the departure of another prominent Goldman banker, Yoel Zaoui, was announced in a separate internal memo. Zaoui shared the title of M&A co-head with Sykes and had also been on the management committee.

Sykes, who is based in Los Angeles, is also chairman of the global technology, media and telecommunications department of the investment banking division. He is a member of Goldman's internal Business Standards Committee.

The Goldman veteran joined the firm in 1984 and became a partner in 1992. He has advised on several high-profile deals, including Walt Disney Co's (>> The Walt Disney Company) acquisition of Pixar, Aetna Inc's (>> Aetna Inc.) acquisition of U.S. Healthcare and Roche Holding AG acquisition of Genentech.

"Gene has played a vital role in strengthening our investment banking franchise, particularly with respect to many of the most significant companies in technology and media," Blankfein and Cohn said in the memo, whose contents were confirmed by a spokesman.

(Reporting By Lauren Tara LaCapra in New York; editing by Andre Grenon)

By Lauren Tara LaCapra

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AETNA INC
07/25DJThe Boss Wants You Back in the Office
07/20 AETNA : to Announce Second-Quarter 2017 Results
07/11 AETNA INC : ex-dividend day
07/07 AETNA INC : Dividend Coverage: Aetna has a Dividend Yield of 1.30%; Will Trade E..
06/30DJAETNA : Picks Manhattan for New Home -- WSJ
06/29DJAETNA : to Move Headquarters to New York -- Update
06/29 AETNA : to leave Connecticut headquarters for New York City
06/29DJAETNA : to Move Corporate Headquarters to New York City
06/21 AETNA : and Community Care Physician Network Sign Collaborative Agreement
06/20 U.S. banks, corporations establish principles for cyber risk ratings firms
More news
News from SeekingAlpha
07/26 Obamacare repeal fails in Senate
07/25 Senate Republicans not bailing on healthcare plan just yet, procedural vote t..
07/24 ANTHEM : Tread Carefully Into Earnings
07/20 Overnight GOP healthcare meeting
07/19 GOP mulling working with Dems on healthcare plan
Financials ($)
Sales 2017 61 029 M
EBIT 2017 4 297 M
Net income 2017 1 869 M
Debt 2017 2 991 M
Yield 2017 0,88%
P/E ratio 2017 29,53
P/E ratio 2018 16,75
Capi. / Sales 2017 0,90x
Capi. / Sales 2018 0,81x
Capitalization 51 828 M
Chart AETNA INC
Duration : Period :
Aetna Inc Technical Analysis Chart | AET | US00817Y1082 | 4-Traders
Technical analysis trends AETNA INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 157 $
Spread / Average Target 0,48%
EPS Revisions
Managers
NameTitle
Mark T. Bertolini Chairman & Chief Executive Officer
Karen S. Lynch President
Margaret M. McCarthy Executive Vice President-Operations & Technology
Shawn M. Guertin CFO, Executive VP & Chief Enterprise Risk Officer
Harold L. Paz Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC26.00%51 828
UNITEDHEALTH GROUP18.97%183 481
ANTHEM INC32.61%50 501
CIGNA CORPORATION30.30%44 498
HUMANA INC15.14%33 901
CENTENE CORP49.94%14 273